So What’s the Deal with ICHRA?

The number of US employees offered ICHRAs continues to grow. Yet, headwinds – including competition, individual coverage market uncertainty, and complexity – may hamper the ICHRA opportunity.  The post So What’s the Deal with ICHRA? appeared first on MedCity News.

Read More

ISPOR’s 2024 HEOR Awards

Who won the ISPOR’s 2024 HEOR awards? The list is below. Avedis Donabedian Lifetime Achievement Award: C. Daniel Mullins, PhD; Professor of Practice, Sciences, and Health Outcomes Research and Executive Director of The PATIENTS Program; University of Maryland School of Pharmacy; Baltimore, MD, USAMarilyn Dix Smith Leadership Award: Deborah Marshall, PhD; Professor and Svare Chair…

Read More

En Colorado, comienzan a usar hongos psicódelicos para experimentación terapéutica

BOULDER, Colorado — Los organismos reguladores de Colorado están emitiendo licencias que permiten suministrar hongos psicodélicos con fines terapéuticos. A fines de la primavera o principios del verano es posible que ya estén autorizados los primeros “centros de sanación” estatales, donde se podrán consumir los hongos bajo supervisión. Esto ocurre casi dos años después de…

Read More